Revvity (RVTY) P/E (2010 - 2026)
Revvity (RVTY) P/E from Apr 5, 2010 to Jun 3, 2026. The TTM Revvity (RVTY) P/E is 47.82. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Revvity (RVTY)
| Year | P/E | Change |
|---|---|---|
| 2026 | 47.82 | +3.92% |
| 2025 | 46.01 | -8.61% |
| 2024 | 50.35 | +171.47% |
| 2023 | 18.55 | -33.80% |
| 2022 | 28.01 | +39.13% |
| 2021 | 20.14 | -48.19% |
| 2020 | 38.86 | -18.00% |
| 2019 | 47.39 | +29.57% |
| 2018 | 36.58 | +81.15% |
| 2017 | 20.19 | -16.40% |
| 2016 | 24.15 | -30.01% |
| 2015 | 34.51 | +10.32% |
| 2014 | 31.28 | +12.97% |
| 2013 | 27.69 | -46.48% |
| 2012 | 51.74 | +760.86% |
| 2011 | 6.01 | -81.13% |
| 2010 | 31.85 | N/A |
Comparison Revvity (RVTY) P/E with competitors
Revvity (RVTY) P/E is 47.82.
| Ticker | Name | P/E | Upside |
|---|---|---|---|
| ADVB | Advanced Biomed Inc | 0.78 | -98.37% |
| MBAI | CheckCap Ltd | 2.88 | -93.97% |
| FONR | Fonar Corp | 15.41 | -67.77% |
| QGEN | Qiagen NV | 17.55 | -63.30% |
| IQV | IQVIA Holdings Inc | 20.25 | -57.65% |
| DGX | Quest Diagnostics Inc | 21.62 | -54.79% |
| LH | Laboratory Corp Of America Holdings | 22.66 | -52.61% |
| A | Agilent Technologies Inc | 25.45 | -46.78% |
| MEDP | Medpace Holdings Inc | 26.32 | -44.95% |
| TMO | Thermo Fisher Scientific Inc | 26.87 | -43.81% |
| MTD | Mettler-Toledo International Inc | 26.96 | -43.62% |
| DHR | Danaher Corp | 33.26 | -30.45% |
| ILMN | Illumina Inc | 34.97 | -26.86% |
| ICLR | Icon Plc | 39.55 | -17.30% |
| IDXX | Idexx Laboratories Inc | 40.14 | -16.06% |
| VCYT | Veracyte Inc | 40.15 | -16.02% |
| SHC | Sotera Health Company | 63.43 | +32.65% |
| WAT | Waters Corp | 93.81 | +96.18% |